Skip to content

Clinical trials

Observational Leukemia, Myeloid, Acute trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Observational Country / region: France Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20051
20091
20111
20121
20133
20144
20151
20161
20174
20182
20193
20202
20214
20224
20234
20248
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Unknown status13
Recruiting10
Active, not recruiting3
Not yet recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospices Civils de Lyon12
Assistance Publique - Hôpitaux de Paris7
French Innovative Leukemia Organisation5
Nantes University Hospital3
University Hospital, Angers2
University Hospital, Bordeaux2
Acute Leukemia French Association1
Bristol-Myers Squibb1
Centre Hospitalier Universitaire de Nice1
Centre Hospitalier Universitaire de Saint Etienne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute50
Myelodysplastic Syndromes6
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Breast Neoplasms2
Colonic Neoplasms2
Infections2
Leukemia, Biphenotypic, Acute2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myelomonocytic, Chronic2
Myeloproliferative Disorders2

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.